A novel conformationally restricted protein kinase C inhibitor, Ro 31‐8425, inhibits human neutrophil superoxide generation by soluble, particulate and post‐receptor stimuli

Authors:
  • MDM.Maureen Dale
    M.Maureen Dale
  • PDPeter D. Davis
    Peter D. Davis
  • LELucy H. Elliott
    Lucy H. Elliott
  • CHChristopher H. Hill
    Christopher H. Hill
  • HKHari Kumar
    Hari Kumar
  • GLGeoffrey Lawton
    Geoffrey Lawton
  • BTBreda M. Twomey
    Breda M. Twomey
  • JWJulie Wadsworth
    Julie Wadsworth
  • SWSandra E. Wilkinson
    Sandra E. Wilkinson
  • JNJohn S. Nixon
    John S. Nixon

Abstract
A novel, bis‐indolylmaleimide, Ro 31‐8425, bearing a conformationally restricted side chain, inhibits protein kinase C isolated from rat brain and human neutrophils with a high degree of selectivity over cAMP‐dependent kinase and Ca2−/calmodulin‐dependent kinase. It also inhibits phorbol ester‐induced intracellular events known to be mediated by protein kinase C(p47 phosphorylation in intact platelets, CD3 and CD4 down‐regulation in T‐cells). Ro 31‐8425 inhibited superoxide generation in human neutrophils activated by both receptor stimuli (formyl‐methionyl‐leucylphenylalanine, opsonized zymosan. IgG and heat aggregated IgG) and post‐rcceptor stimuli (1,2‐dioctanoylglycerol and fluoride). The compound also blocked antigen driven, but not IL‐2 induced, T‐cell proliferation. These results support a central role for protein kinase C in the activation of the respiratory burst and antigen‐driven T‐cell proliferation.

This publication has 23 references indexed in Scilit: